SEARCH

SEARCH BY CITATION

References

  • ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol., 14, 4858.
  • BÖHME, E., GRAF, H. & SCHULTZ, G. (1978). Effects of sodium nitroprusside and other smooth muscle relaxants on cyclic GMP formation in smooth muscle and platelets. Advances Cyclic Nucleotide Research, 9, 131143.
  • CHASIN, M. & HARRIS, D.N. (1976). Inhibitors and activators of cyclic nucleotide phosphodiesterases. Advances Cyclic Nucleotide Research, 7, 223264.
  • CHIBA, T., YAMAGUCHI, A., YAMATANI, T., NAKAMURA, A., MORISHITA, T., INUI, T., FUKASE, M., NODA, T. & FUJITA, T. (1989). Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am. J. Physiol., 256 (Endocrinol. Metab. 19), E331E335.
  • DEMESY-WAELDELE, F. & STOCLET, J.C. (1977). Effect of papaverine on cyclic nucleotide levels in the isolated rat aorta. Eur. J. Pharmacol., 46, 6366.
  • DOODS, H., HALLERMAYER, G., WU, D., ENTZEROTH, M., RUDOLF, K., ENGEL, W. & EBERLEIN, W. (2000). Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br. J. Pharmacol., 129, 429423.
  • EDVINSSON, L., GULBENKIAN, S., BARROSO, C., CUNHA E SÁ, M., POLAK, J. M., MORTENSEN, A., JØRGENSEN, L. & JANSEN-OLESEN, I. (1998). Innervation of the human middle meningeal artery: immunohistochemistry, ultrastructure, and role of endothelium for vasomotility. Peptides, 19, 12131225.
  • EDVINSSON, L., SAMS, A., JANSEN-OLESEN, I., TAJTI, J., KANE, S.A., RUTLEDGE, R.Z., KOBLAN, K.S., HILL, R.G. & LONGMORE, J. (2001). Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries. Eur. J. Pharmacol., 415, 3944.
  • EVANS, B.N., ROSENBLATT, M. I., MNAYER, L. O., OLIVER, K.R. & DICKERSON, I.M. (2000). CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J. Biol. Chem., 275, 3143831443.
  • FUJIOKA, M. (1984). Lack of causal relationship between the vasodilator effect of papaverine and cyclic AMP production in the dog basilar artery. Br. J. Pharmacol., 83, 113124.
  • GOADSBY, P.J., EDVINSSON, L. & EKMAN, R. (1988). Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann. Neurol., 23, 193196.
  • GOADSBY, P.J., EDVINSSON, L. & EKMAN, R. (1990). Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann. Neurol., 28, 183187.
  • GRAHAM, J.P. & WOLFF, H.G. (1938). Mechanism of migraine headache and the action of ergotamine tartrate. Arch. Neurol. Psychiatry, 39, 737763.
  • HAMEL, E., ASSUMEL-LURDIN, C., EDVINSSON, L., FAGE, D. & MACKENZIE, E.T. (1987). Neuronal versus endothelial origin of vasoactive acetylcholine in pial vessels. Brain Research, 420, 391396.
  • JANSEN, I., UDDMAN, R., HOCHERMAN, M., EKMAN, R., JENSEN, K., OLESEN, J., STIERNHOLM, P. & EDVINSSON, L. (1986). Localization and effects of neuropeptide Y, vasoactive intestinal polypeptide, substance P, and calcitonin gene-related peptide in human temporal arteries. Ann. Neurol., 20, 496501.
  • JANSEN-OLESEN, I., GULBENKIAN, S., VALENÇA, A., ANTUNES, J.L., WHARTON, J., POLAK, J.M. & EDVINSSON, L. (1995). The peptidergic innervation of the human superficial temporal artery: immunohistochemistry, ultrastructure, and vasomotility. Peptides, 16, 275287.
  • JANSEN-OLESEN, I., MORTENSEN, A. & EDVINSSON, L. (1996). Calcitonin gene-related peptide is released from capsaicin-sensitive nerve fibres and induces vasodilatation of human cerebral arteries concomitant with activation with adenylyl cyclase. Cephalalgia, 16, 310316.
  • JANSEN-OLESEN, I., OTTOSSON, A., CANTERA, L., STRUCK, S., LASSEN, L.H., OLESEN, J., MORTENSEN, A., ENGEL, U. & EDVINSSON, L. (1997). Role of the endothelium and nitric acid in histamine-induced responses in human cranial arteries and detection of mRNA encoding H1- and H2-receptors by RT–PCR. Br. J. Pharmacol., 121, 4148.
  • KANEDA, T., SHIMIZU, K., NAKAJYO, S. & URAKAWA, N. (1998). The difference in the inhibitory mechanisms of papaverine on vascular and intestinal smooth muscles. Eur. J. Pharmacol., 355, 149157.
  • KAUMANN, A.J. (1990). Piglet sinoatrial 5-HT receptors resemble human atrial 5-HT4-like receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 342, 619622.
  • LANCE, J.W. (1992). History of involvement of 5-HT in primary headaches. In 5-Hydroxytryptamine Mechanisms in Primary Headaches, Vol 2., ed. Olesen, J., Saxena, P.R. pp. 1928. New York: Raven Press.
  • MCLATCHIE, L.M., FRASER, N.J., MAIN, M.J., WISE, A., BROWN, J., THOMPSON, N., SOLARI, R., LEE, M.G. & FOORD, S.M. (1998). RAMPs regulate the transport and ligand specificity of the calcitonin receptor-like receptor. Nature, 393, 333339.
  • MIYOSHI, H. & NAKAYA, Y. (1995). Calcitonin gene-related peptide activates the K+ channels of vascular smooth muscle cells via adenylate cyclase. Basic Res. Cardiol., 90, 332336.
  • NELSON, M.T., HUANG, Y., BRAYDEN, J.E., HESCHELER, J. & STANDEN, N.B. (1990). Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels. Nature, 344, 770773.
  • QUAYLE, J.M., BONEV, A.D., BRAYDEN, J.E. & NELSON, M.T. (1994). Calcitonin gene-related peptide activated ATP-sensitive K+ currents in rabbit arterial smooth muscle via protein kinase A. J. Physiol., 475, 913.
  • SAMS, A., KNYIHAR-CSILLIK, E., ENGBERG, J., SZOK, D., TAJTI, J., BODI, I., EDVINSSON, L., VECSEI, L. & JANSEN-OLESEN, I. (2000). CGRP and adrenomedullin receptor populations in human cerebral arteries: in vitro pharmacological and molecular investigations in different artery sizes. Eur. J. Pharmacol., 408, 183193.
  • SCHUBERT, R. & NELSON, M.T. (2001). Protein kinases: tuners of the BKCa channel in smooth muscle. Trends Pharmacological Sciences, 22, 505512.
  • UDDMAN, R., EDVINSSON, L., JANSEN, I., STIERNHOLM, P., JENSEN, K., OLESEN, J. & SUNDLER, F. (1986). Peptide-containing nerve fibres in human extracranial tissue: a morphological basis for neuropeptide involvement in extracranial pain. Pain, 27, 391399.
  • VERHEGGEN, R. (2000). Untersuchungen an der 5-HT-induzierten Kontraktion beteiligten Serotoninrezeptoren bei menschlichen Temporalarterien. ISBN 3-8265-8074-5 Shaker-Verlag, Aachen.
  • VERHEGGEN, R., BUMANN, K., WEBEL, M., MEIER, A. & KAUMANN, A.J. (2001). BIBN4096BS is a potent antagonist of the relaxant effects of CGRP on human temporal artery. Naunyn-Schmiedeberg's Arch. Pharmacol., 363, R36.
  • VERHEGGEN, R., FREUDENTHALER, S., MEYER-DULHEUER, F. & KAUMANN, A.J. (1996). Participation of 5-HT1-like and 5-HT2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs. Br. J. Pharmacol., 117, 283292.
  • VERRECCHIA, C., SERCOMBE, V., PHILIPSON, V. & SEYLAZ, J. (1986). Functional destruction of cerebral vascular endothelium by Triton X-100. Blood Vessels, 23, 106.